89bio shares are trading higher after after Evercore ISI Group initiated coverage on the stock with an Outperform rating and announced a $49 price target.
Portfolio Pulse from Benzinga Newsdesk
89bio shares are trading higher after Evercore ISI Group initiated coverage on the stock with an Outperform rating and a $49 price target.
June 13, 2023 | 4:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evercore ISI Group initiated coverage on 89bio with an Outperform rating and a $49 price target, leading to higher trading.
The Outperform rating and $49 price target from Evercore ISI Group indicate a positive outlook for 89bio, which is likely to result in increased investor interest and higher trading in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100